MicuRx Pharmaceuticals Lands $55,000,000 Series C Funding

  • Feed Type
  • Date
    9/28/2016
  • Company Name
    MicuRx Pharmaceuticals
  • Mailing Address
    3916 Trust Way Hayward, CA 94545 USA
  • Company Description
    MicuRx is discovering and developing next-generation antibacterial andantifungal products. By making specific modifications to validatedantibiotics, MicuRx intends to improve overall pharmacological propertiesof antimicrobial drugs in order to overcome antibiotic resistance.
  • Website
    http://www.micurx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Funding from Series C financing will be used to continue development of MRX-I in both the United States and China.
  • M&A Terms
  • Venture Investor
    GP Capital
  • Venture Investor
    3E Bioventures
  • Venture Investor
    Delin Capital

Trending on Xconomy